SE452984B - Karbostyrilderivat - Google Patents

Karbostyrilderivat

Info

Publication number
SE452984B
SE452984B SE8204677A SE8204677A SE452984B SE 452984 B SE452984 B SE 452984B SE 8204677 A SE8204677 A SE 8204677A SE 8204677 A SE8204677 A SE 8204677A SE 452984 B SE452984 B SE 452984B
Authority
SE
Sweden
Prior art keywords
group
reaction
general formula
compound
acid
Prior art date
Application number
SE8204677A
Other languages
English (en)
Swedish (sv)
Other versions
SE8204677D0 (sv
SE8204677L (sv
Inventor
M Tominaga
Y-H Yang
H Ogawa
K Nakagawa
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP56137984A external-priority patent/JPS5838258A/ja
Priority claimed from JP56210368A external-priority patent/JPS58110568A/ja
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of SE8204677D0 publication Critical patent/SE8204677D0/xx
Publication of SE8204677L publication Critical patent/SE8204677L/xx
Publication of SE452984B publication Critical patent/SE452984B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/227Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
SE8204677A 1981-09-01 1982-08-13 Karbostyrilderivat SE452984B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP56137984A JPS5838258A (ja) 1981-09-01 1981-09-01 カルボスチリル誘導体
JP56210368A JPS58110568A (ja) 1981-12-25 1981-12-25 カルボスチリル誘導体

Publications (3)

Publication Number Publication Date
SE8204677D0 SE8204677D0 (sv) 1982-08-13
SE8204677L SE8204677L (sv) 1983-03-02
SE452984B true SE452984B (sv) 1988-01-04

Family

ID=26471144

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8204677A SE452984B (sv) 1981-09-01 1982-08-13 Karbostyrilderivat

Country Status (21)

Country Link
US (1) US4514401A (pt)
KR (1) KR860000135B1 (pt)
AR (2) AR241905A1 (pt)
AT (1) AT383592B (pt)
AU (1) AU532361B2 (pt)
BE (1) BE894105A (pt)
CA (1) CA1205807A (pt)
CH (1) CH650783A5 (pt)
DE (1) DE3230209C2 (pt)
DK (1) DK166877B1 (pt)
ES (5) ES514992A0 (pt)
FI (1) FI78688C (pt)
FR (1) FR2512019B1 (pt)
GB (1) GB2108109B (pt)
IT (1) IT1156490B (pt)
NL (1) NL8203225A (pt)
NO (1) NO159591C (pt)
PH (1) PH18055A (pt)
PT (1) PT75424B (pt)
SE (1) SE452984B (pt)
SU (1) SU1356962A3 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH17194A (en) * 1980-03-06 1984-06-19 Otsuka Pharma Co Ltd Novel carbostyril derivatives,and pharmaceutical composition containing the same
FR2557570B1 (fr) * 1984-01-04 1986-04-18 Adir Nouveaux derives de la quinoleine, leur procede de preparation et les compositions pharmaceutiques les renfermant
DE3423003A1 (de) * 1984-06-22 1986-01-02 Beiersdorf Ag, 2000 Hamburg Benzo(c)(1,8)naphthyridine, verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen
DE3431303A1 (de) * 1984-08-25 1986-02-27 Goedecke Ag 1,6-naphthyridin-derivate, verfahren zu deren herstellung und deren verwendung
DE3784401T2 (de) * 1986-07-31 1993-08-12 Otsuka Pharma Co Ltd Karbostyril-derivate und ihre salze, verfahren zu ihrer herstellung und diese enthaltende kardiotonische zusammensetzung.
JPH0696555B2 (ja) * 1986-07-31 1994-11-30 大塚製薬株式会社 カルボスチリル誘導体
US5098477A (en) * 1988-12-14 1992-03-24 Ciba-Geigy Corporation Inks, particularly for ink printing
JP2686887B2 (ja) * 1992-08-11 1997-12-08 キッセイ薬品工業株式会社 ピペリジノ−3,4−ジヒドロカルボスチリル誘導体
SG151250A1 (en) * 2003-12-10 2009-04-30 Janssen Pharmaceutica Nv Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2- quinoxalinones as poly(adp-ribose) polymerase inhibitors
NZ597107A (en) 2009-06-25 2013-12-20 Alkermes Pharma Ireland Ltd Heterocyclic compounds for the treatment of neurological and psychological disorders
JP5857040B2 (ja) 2010-05-04 2016-02-10 アルカーメス ファーマ アイルランド リミテッド 酸化ラクタム化合物の合成方法
RU2448698C2 (ru) * 2010-06-21 2012-04-27 Государственное образовательное учреждение высшего профессионального образования "Нижегородская государственная медицинская академия Федерального Агентства по здравоохранению и социальному развитию" (ГОУ ВПО НижГМА Росздрава) Способ восстановления синусового ритма при трепетании предсердий i типа
ES2691671T3 (es) 2010-06-24 2018-11-28 Alkermes Pharma Ireland Limited Profármacos de compuestos NH-acídicos: derivados de éster, carbonato, carbamato y fosfonato

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5118771A (ja) * 1974-08-07 1976-02-14 Akimitsu Takeya Bantaioshigatanitaisuru keshoshiitotenchakuho
US4081447A (en) * 1975-04-09 1978-03-28 Abbott Laboratories 5-[2-Hydroxy-3-(3,4-dimethoxy phenethylamino)]-propoxy-3,4-dihydro carbostyril and pharmaceutically acceptable salts thereof
JPS597707B2 (ja) * 1975-06-23 1984-02-20 オオツカセイヤク カブシキガイシヤ カルボスチリルユウドウタイノ セイゾウホウ
JPS52283A (en) * 1975-06-23 1977-01-05 Otsuka Pharmaceut Co Ltd Process for preparation of carbostyril derivatives
GB1589871A (en) * 1976-07-19 1981-05-20 Conder Group Serv Ltd Tank construction
JPS5416478A (en) * 1977-07-08 1979-02-07 Otsuka Pharmaceut Co Ltd 3,4-dihydrocarbostyril herivative
DE2853996A1 (de) * 1978-12-14 1980-07-03 Hoechst Ag Neue substituierte phenylpiperazinderivate und verfahren zu deren herstellung
JPS5585520A (en) * 1978-12-22 1980-06-27 Otsuka Pharmaceut Co Ltd Remedy for peptic ulcer
DE2928583A1 (de) * 1979-07-14 1981-01-29 Thomae Gmbh Dr K Verfahren zur herstellung von carbostyrilderivaten
PH17194A (en) * 1980-03-06 1984-06-19 Otsuka Pharma Co Ltd Novel carbostyril derivatives,and pharmaceutical composition containing the same
FI77852C (fi) * 1981-02-17 1989-05-10 Otsuka Pharma Co Ltd Foerfarande foer framstaellning av nya, saosom hjaertmediciner anvaendbara substituerade amid- och (maettad heterocykel)karbonylkarbostyrilderivat.

Also Published As

Publication number Publication date
FR2512019A1 (fr) 1983-03-04
GB2108109A (en) 1983-05-11
AR241905A1 (es) 1993-01-29
AU532361B2 (en) 1983-09-29
ES536982A0 (es) 1985-07-01
PT75424A (en) 1982-09-01
ES521472A0 (es) 1984-05-16
GB2108109B (en) 1985-05-09
CA1205807A (en) 1986-06-10
ES8405000A1 (es) 1984-05-16
PH18055A (en) 1985-03-18
ES521473A0 (es) 1984-05-16
FR2512019B1 (fr) 1986-01-03
DE3230209C2 (de) 1985-08-22
SE8204677D0 (sv) 1982-08-13
KR840001157A (ko) 1984-03-28
NO159591C (no) 1989-01-18
SE8204677L (sv) 1983-03-02
AR240918A1 (es) 1991-03-27
ATA310682A (de) 1986-12-15
CH650783A5 (de) 1985-08-15
PT75424B (en) 1985-01-04
KR860000135B1 (ko) 1986-02-26
ES8506302A1 (es) 1985-07-01
DE3230209A1 (de) 1983-03-10
NO822749L (no) 1983-03-02
ES521471A0 (es) 1984-11-01
SU1356962A3 (ru) 1987-11-30
ES8401058A1 (es) 1983-11-16
ES514992A0 (es) 1983-11-16
BE894105A (fr) 1983-02-14
ES8500933A1 (es) 1984-11-01
NL8203225A (nl) 1983-04-05
FI822803A0 (fi) 1982-08-11
AT383592B (de) 1987-07-27
DK361982A (da) 1983-03-02
AR240918A2 (es) 1991-03-27
US4514401A (en) 1985-04-30
FI822803L (fi) 1983-03-02
FI78688C (fi) 1989-09-11
NO159591B (no) 1988-10-10
IT8268020A0 (it) 1982-08-16
FI78688B (fi) 1989-05-31
ES8405001A1 (es) 1984-05-16
AU8698082A (en) 1983-04-14
IT1156490B (it) 1987-02-04
DK166877B1 (da) 1993-07-26

Similar Documents

Publication Publication Date Title
DE68915900T2 (de) Angiogenese hemmendes Mittel.
DE60126643T2 (de) Heteroarylalkylpiperazin-derivate als hemmstoffe der fettsäureoxidation
SE452984B (sv) Karbostyrilderivat
US20030120072A1 (en) Decahydro-isoquinolines
SE445348B (sv) Karbostyrilderivat, forfarande for framstellning derav och hjertsterkande komposition som innehaller detsamma
US3852291A (en) Heterocyclic derivatives of phenoxypropanolamines
EP0124476B1 (de) Carboxamide, Verfahren zur Herstellung und pharmazeutische Präparate, die diese enthalten
JPS63201167A (ja) 杭不整脈薬
EP0416581A1 (en) Substituted N-benzylpiperidine amides
JPS5849366A (ja) 3,4−ジヒドロカルボスチリル誘導体
EP0004532A1 (de) 1-Aryloxy-3-nitratoalkylamino-2-propanole, Verfahren zu ihrer Herstellung und ihre pharmazeutischen Zubereitungen
US3953456A (en) Carbostyril derivatives and process for preparing the same
EP0410208A1 (de) Chromanderivate
EP0255894B1 (de) Pyrimidinderivate, deren Herstellung und Arzneimittel, die diese Derivate enthalten
US5028616A (en) N-benzylpiperidine amides
JPS6338005B2 (pt)
EP0256400A2 (de) Pyrimidinderivate, ihre Herstellung und Medikamente die diese Derivate enthalten
DE2155132A1 (de) l-(2-Hydroxy-3-phenoxy- oder-phenylthic~propyl)-piperazin-Derivate
EP0011747B1 (de) Aminopropanolderivate des 6-Hydroxy-2,3,4,5-tetrahydro-1H-1-benzazepin-2-ons, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
DE3874465T2 (de) 1,2,3,4-tetrahydroisochonoline als antiarrhythmische mittel.
DE3228992A1 (de) Spirothiazolidindion-derivate, herstellung dieser verbindungen und diese enthaltende pharmazeutische praeparate
US5053413A (en) N-benzylpiperidineisoindolinones
EP0187639B1 (en) Novel piperazine derivatives, processes for production thereof, and pharmaceutical compositions comprising said compounds as active ingredient
DD210266A5 (de) Verfahren zur herstellung von 3-(ureidocyclohexylamino)-propan-1,2-diolderivaten
DE2656227C2 (de) Basisch alkylierte Diphenyldisulfid-2,2'-biscarbonsäureamide, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8204677-2

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8204677-2

Format of ref document f/p: F